Overview

Phase 2, Open Label, Randomized, Active Controlled Pilot Study MW-III vs Silver Sulfadiazine Second Degree Thermal Burns

Status:
Not yet recruiting
Trial end date:
2023-03-12
Target enrollment:
Participant gender:
Summary
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" in second-degree thermal burns
Phase:
Phase 2
Details
Lead Sponsor:
Skingenix, Inc.
Treatments:
Silver Sulfadiazine
Sulfadiazine